Clinical Trial Update: Dipyridamole for Immune Activation in HIV [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for dipyridamole investigating immune activation in HIV, completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Sharon Riddler | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-11